GRI Bio, Inc.

GRI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B3 Aug 28, 2024 424B3
424B3 Aug 28, 2024 424B3
DEFA14A Aug 23, 2024 DEFA14A
DEFA14A Aug 23, 2024 DEFA14A
8-K Aug 23, 2024 8-K
DEFA14A Aug 16, 2024 DEFA14A
8-K Aug 14, 2024 8-K
10-Q Aug 14, 2024 10-Q
ARS Aug 2, 2024 ARS
DEF 14A Aug 2, 2024 DEF 14A
8-K Jul 26, 2024 8-K
424B5 Jul 26, 2024 424B5
PRE 14A Jul 23, 2024 PRE 14A
8-K Jul 19, 2024 8-K
424B5 Jul 19, 2024 424B5
8-K Jul 8, 2024 8-K
424B4 Jun 27, 2024 424B4
8-K Jun 27, 2024 8-K
EFFECT Jun 26, 2024
S-1/A Jun 26, 2024 S-1/A
S-1/A Jun 26, 2024 S-1/A
CORRESP Jun 25, 2024
CORRESP Jun 25, 2024
UPLOAD Jun 24, 2024
S-1 Jun 20, 2024 S-1
← Newer Page 6 of 17 · 401 filings Older →